| Code | Description | Claims | Beneficiaries | Total Paid |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,093 |
1,966 |
$33K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,125 |
3,704 |
$31K |
| 80061 |
Lipid panel |
1,907 |
1,811 |
$26K |
| 80053 |
Comprehensive metabolic panel |
2,405 |
2,242 |
$24K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,513 |
715 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
280 |
259 |
$14K |
| 86328 |
|
703 |
670 |
$13K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
975 |
927 |
$10K |
| 81000 |
|
2,813 |
2,623 |
$9K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
290 |
266 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
706 |
669 |
$6K |
| 86703 |
|
427 |
420 |
$5K |
| 86738 |
|
299 |
291 |
$4K |
| 87088 |
|
393 |
367 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
392 |
366 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
53 |
53 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
187 |
160 |
$2K |
| 84436 |
|
218 |
217 |
$2K |
| 82274 |
|
77 |
75 |
$1K |
| 84153 |
|
59 |
53 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
40 |
39 |
$1K |
| 84439 |
|
108 |
104 |
$1K |
| 82043 |
|
146 |
140 |
$874.60 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
23 |
23 |
$842.08 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
23 |
23 |
$838.85 |
| 84479 |
|
132 |
131 |
$834.47 |
| 86592 |
|
85 |
85 |
$381.91 |
| 80050 |
General health panel |
13 |
13 |
$128.41 |
| 85730 |
|
13 |
13 |
$83.67 |
| 85610 |
|
13 |
13 |
$54.88 |
| 85651 |
|
15 |
14 |
$52.65 |